FDA Approves Drug for Rare Cancer
Jul 25, 2022
CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.
<p>Nocturnal enuresis is wetting while asleep in children 5 years of age and older. A child with nocturnal enuresis wets only during sleep and urinates normally when awake.</p>
Jul 25, 2022
CHOP played an instrumental role in leading one of two clinical trials that led to the approval of Xalkori® for unresectable, recurrent, or refractory ALK-positive IMT.
Jul 22, 2022
In April, the Office of Community Impact officially welcomed John William Chin as the new CHOP Cares Community Advisory Board Chair. He has served on CHOP Cares Community Advisory Board for the past three years.
Jul 21, 2022
Children living in the neighborhoods around the Children’s Hospital of Philadelphia campus in West and Southwest Philadelphia have experienced more than their fair share of trauma, which only increased with the COVID-19 pandemic and the rise in gun violence.
Jul 20, 2022
Much progress has been made over the last 25 years when it comes to identifying the genetic mutation that is causing a child’s congenital hyperinsulinism (HI).
Jul 20, 2022
If Leela Morrow, PsyD, the psychologist for the Congenital Hyperinsulinism Center at Children’s Hospital of Philadelphia, gives your child a referral for a neuropsychology evaluation it’s nothing to be afraid of. In fact, it may give your child a roadmap to success.
Jul 20, 2022
Many children with hyperinsulinism (HI) have feeding aversion — as many as 60%. The use of tube feedings, and possibly continuous dextrose, to control their blood sugar, among other things (effect of medications, the appetite suppressing effects of insulin, etc.), may exacerbate their aversion to eating by mouth.
Jul 21, 2022
Funding aims to reduce health disparities for patient and families living in West Philadelphia, extending CHOP’s overall community impact.
Jul 20, 2022
Children’s Hospital of Philadelphia (CHOP) has been recognized by the 2022 Disability Equality Index (DEI) as a leader in “Best Places to Work for Disability Inclusion.” The DEI is the nation’s most comprehensive annual benchmarking tool used to survey employers’ disability policies, practices, and initiatives. For the fourth year in a row, CHOP received a 100 out of 100 score, the DEI’s highest ranking.
Jul 19, 2022
CHOP partnered with the Eastern Minority Supplier Development Council to host its first matchmaker event targeted towards construction, facilities and building trades. The virtual event offered attendees the opportunity to learn more about CHOP, our supplier diversity program, future bid opportunities, and to meet with CHOP’s senior leaders, facilities and construction teams.
Jul 18, 2022
A new policy statement on vision disorders after head injuries from the American Academy of Pediatrics is supported by leading ophthalmology organizations.